Mood Disorders & Psychiatry
Treatment Resistant Depression (TRD)
Treatment Resistant Depression (TRD) affects millions of individuals who do not respond adequately to standard antidepressant therapies. CenExel partners with sponsors to advance innovative psychiatric research through experienced investigators, diverse patient populations, and high-performing clinical trial sites dedicated to improving outcomes for patients living with depression.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Advancing Clinical Research for Treatment Resistant Depression
CenExel provides specialized support for Treatment Resistant Depression clinical trials across early and late-phase studies. Our experienced psychiatric research teams combine scientific expertise, operational excellence, and patient-centered recruitment strategies to help sponsors accelerate development timelines while maintaining exceptional data quality.
With access to diverse patient populations and established psychiatric investigators, CenExel delivers scalable solutions for complex CNS and mood disorder studies.
Conditions Covered
TRD & Mood Disorders We Research
Our psychiatric research sites support a broad range of depressive and mood-related conditions through innovative clinical studies and advanced therapeutic research.
- Treatment Resistant Depression (TRD)
- Major Depressive Disorder (MDD)
- Bipolar Depression
- Persistent Depressive Disorder
- Generalized Anxiety Disorder
- Postpartum Depression
- Suicidal Ideation Studies
- Adolescent Depression
Our Approach
Why Sponsors Choose CenExel for TRD Research
Experienced CNS and psychiatric investigators with extensive TRD trial expertise.
01
Specialized Psychiatric Investigators
Our experienced investigators provide deep expertise in anxiety disorders, patient care, and psychiatric trial execution.
02
Biomarker & Assessment Support
Advanced psychiatric assessments and biomarker-driven research support.
03
Diverse Patient Access
Nationwide recruitment capabilities across diverse demographic populations.
04
Faster Enrollment Performance
Optimized recruitment workflows designed to improve enrollment efficiency and retention.
Phase Coverage
Supported TRD Trial Phases
CenExel supports sponsors across all stages of Treatment Resistant Depression clinical research — from first-in-human studies to Phase IV post-marketing psychiatric trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our psychiatric research network supports innovative CNS therapies including rapid-acting antidepressants, neuromodulation therapies, and emerging TRD treatment approaches.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.
